Medclair AB (NGM:MCLR)
Sweden
· Delayed Price · Currency is SEK 2.330
+0.030 (1.30%)
At close: Mar 5, 2026
Medclair AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 56.07 | 35.95 | 42.42 | 28.17 | 13.32 | Upgrade
|
| Revenue Growth (YoY) | 55.96% | -15.25% | 50.60% | 111.49% | 107.70% | Upgrade
|
| Cost of Revenue | 18.02 | 12.6 | 17.66 | 7.76 | 5.8 | Upgrade
|
| Gross Profit | 38.04 | 23.35 | 24.76 | 20.41 | 7.52 | Upgrade
|
| Selling, General & Admin | 27.39 | 24.31 | 21.91 | 19 | 15.32 | Upgrade
|
| Other Operating Expenses | 1.03 | -0.08 | -0.05 | - | -0.09 | Upgrade
|
| Operating Expenses | 33.42 | 29.51 | 27.39 | 24.38 | 20.34 | Upgrade
|
| Operating Income | 4.62 | -6.17 | -2.63 | -3.97 | -12.82 | Upgrade
|
| Interest Expense | -0.49 | -0.23 | -0.37 | -0.08 | -0.11 | Upgrade
|
| Interest & Investment Income | - | 0.19 | 0.2 | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | - | -0.57 | -0.83 | -0.37 | -0.09 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.52 | - | -0 | - | - | Upgrade
|
| EBT Excluding Unusual Items | 4.65 | -6.76 | -3.63 | -4.42 | -13.01 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | 6.1 | 0.85 | -0.57 | - | Upgrade
|
| Pretax Income | 4.65 | -0.66 | -2.78 | -4.99 | -13.01 | Upgrade
|
| Income Tax Expense | - | - | 0.01 | 0.01 | 0.01 | Upgrade
|
| Net Income | 4.65 | -0.66 | -2.79 | -5 | -13.02 | Upgrade
|
| Net Income to Common | 4.65 | -0.66 | -2.79 | -5 | -13.02 | Upgrade
|
| Shares Outstanding (Basic) | 8 | 66 | 93 | 83 | 81 | Upgrade
|
| Shares Outstanding (Diluted) | 8 | 66 | 93 | 83 | 81 | Upgrade
|
| Shares Change (YoY) | -88.32% | -28.47% | 11.40% | 2.41% | - | Upgrade
|
| EPS (Basic) | 0.60 | -0.01 | -0.03 | -0.06 | -0.16 | Upgrade
|
| EPS (Diluted) | 0.60 | -0.01 | -0.03 | -0.06 | -0.16 | Upgrade
|
| Free Cash Flow | 7 | 1.19 | 4.23 | -11.77 | -8.68 | Upgrade
|
| Free Cash Flow Per Share | 0.90 | 0.02 | 0.05 | -0.14 | -0.11 | Upgrade
|
| Gross Margin | 67.85% | 64.94% | 58.38% | 72.46% | 56.45% | Upgrade
|
| Operating Margin | 8.24% | -17.16% | -6.20% | -14.09% | -96.25% | Upgrade
|
| Profit Margin | 8.30% | -1.85% | -6.57% | -17.75% | -97.76% | Upgrade
|
| Free Cash Flow Margin | 12.48% | 3.31% | 9.97% | -41.79% | -65.16% | Upgrade
|
| EBITDA | 9.63 | -1.49 | 1.88 | 0.12 | -8.85 | Upgrade
|
| EBITDA Margin | 17.17% | -4.16% | 4.44% | 0.41% | -66.44% | Upgrade
|
| D&A For EBITDA | 5.01 | 4.67 | 4.52 | 4.09 | 3.97 | Upgrade
|
| EBIT | 4.62 | -6.17 | -2.63 | -3.97 | -12.82 | Upgrade
|
| EBIT Margin | 8.24% | -17.16% | -6.20% | -14.09% | -96.25% | Upgrade
|
| Revenue as Reported | - | 36.71 | 43.32 | 28.44 | 13.41 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.